{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:47:45Z","timestamp":1793818065653,"version":"4.6.1"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872880"],"award-info":[{"award-number":["81872880"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204870"],"award-info":[{"award-number":["82204870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21140905300"],"award-info":[{"award-number":["21140905300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-024-05099-4","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:02:11Z","timestamp":1726808531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Lymphopenia in sepsis: a narrative review"],"prefix":"10.1186","volume":"28","author":[{"given":"Zhibin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"issue":"8","key":"5099_CR1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)\u00a0 Jama. 2016;315(8):775\u201387.","journal-title":"JAMA"},{"issue":"10219","key":"5099_CR2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"1","key":"5099_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10238-024-01340-0","volume":"24","author":"L Petramala","year":"2024","unstructured":"Petramala L, et al. Clinical impact of transient lymphopenia. Clin Exper Med. 2024;24(1):77.","journal-title":"Clin Exper Med"},{"issue":"11","key":"5099_CR4","first-page":"1281","volume":"32","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Chinese expert consensus on diagnosis and management of immunosuppression in sepsis\u00a0 Zhonghua wei Zhong Bing ji jiu yi xue. 2020;32(11):1281\u20139.","journal-title":"Zhonghua wei Zhong Bing ji jiu yi xue"},{"key":"5099_CR5","doi-asserted-by":"crossref","unstructured":"Podd BS, et al. Early, persistent Lymphopenia is Associated with prolonged multiple organ failure and mortality in Septic Children. Crit Care Med; 2023.","DOI":"10.1097\/CCM.0000000000005993"},{"issue":"5","key":"5099_CR6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","volume":"42","author":"AM Drewry","year":"2014","unstructured":"Drewry AM, et al. Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock. 2014;42(5):383\u201391.","journal-title":"Shock"},{"issue":"6","key":"5099_CR7","doi-asserted-by":"crossref","first-page":"ofab169","DOI":"10.1093\/ofid\/ofab169","volume":"8","author":"C Cilloniz","year":"2021","unstructured":"Cilloniz C, et al. Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis. Open Forum Infect Dis. 2021;8(6):ofab169.","journal-title":"Open Forum Infect Dis"},{"issue":"29","key":"5099_CR8","doi-asserted-by":"crossref","first-page":"e16535","DOI":"10.1097\/MD.0000000000016535","volume":"98","author":"J Jiang","year":"2019","unstructured":"Jiang J, et al. Nonviral infection-related lymphocytopenia for the prediction of adult sepsis and its persistence indicates a higher mortality. Medicine. 2019;98(29):e16535.","journal-title":"Medicine"},{"issue":"6","key":"5099_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/SHK.0000000000000347","volume":"43","author":"K-P Chung","year":"2015","unstructured":"Chung K-P, et al. Severe lymphopenia is associated with elevated plasma interleukin-15 levels and increased mortality during severe sepsis. Shock. 2015;43(6):569\u201375.","journal-title":"Shock"},{"issue":"1","key":"5099_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14333","volume":"1499","author":"F Venet","year":"2021","unstructured":"Venet F, et al. Myeloid cells in sepsis-acquired immunodeficiency. Ann N Y Acad Sci. 2021;1499(1):3\u201317.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"5099_CR11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/imcb.12611","volume":"101","author":"S Finfer","year":"2023","unstructured":"Finfer S, et al. Lymphopenia in sepsis-an acquired immunodeficiency? Immunol Cell Biol. 2023;101(6):535\u201344.","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"5099_CR12","doi-asserted-by":"crossref","first-page":"e0256205","DOI":"10.1371\/journal.pone.0256205","volume":"16","author":"JC Andreu-Ballester","year":"2021","unstructured":"Andreu-Ballester JC, et al. Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality. PLoS ONE. 2021;16(8):e0256205.","journal-title":"PLoS ONE"},{"issue":"1","key":"5099_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2022","unstructured":"Torres LK, Pickkers P, van der Poll T. Sepsis-induced immunosuppression. Annual Rev Physiol. 2022;84(1):157\u201381.","journal-title":"Annual Rev Physiol"},{"issue":"9","key":"5099_CR14","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/jcm9092695","volume":"9","author":"N Sommer","year":"2020","unstructured":"Sommer N, et al. Decreased thymic output contributes to Immune defects in septic patients. J Clin Med. 2020;9(9):2695.","journal-title":"J Clin Med"},{"issue":"1","key":"5099_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan L, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020;5(1):33.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"5099_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10495-016-1325-3","volume":"22","author":"T Girardot","year":"2017","unstructured":"Girardot T, et al. Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis. 2017;22(2):295\u2013305.","journal-title":"Apoptosis"},{"issue":"4","key":"5099_CR17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcrc.2012.04.010","volume":"27","author":"PM Roger","year":"2012","unstructured":"Roger PM, et al. The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells. J Crit Care. 2012;27(4):384\u201393.","journal-title":"J Crit Care"},{"issue":"11","key":"5099_CR18","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","volume":"166","author":"RS Hotchkiss","year":"2001","unstructured":"Hotchkiss RS, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4\u2009+\u2009T lymphocytes in humans. J Immunol. 2001;166(11):6952\u201363.","journal-title":"J Immunol"},{"issue":"10","key":"5099_CR19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-019-2015-1","volume":"10","author":"C Cao","year":"2019","unstructured":"Cao C, Yu M, Chai Y. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019;10(10):782\u2013782.","journal-title":"Cell Death Dis"},{"issue":"10","key":"5099_CR20","doi-asserted-by":"crossref","first-page":"e1007405","DOI":"10.1371\/journal.ppat.1007405","volume":"14","author":"IJ Jensen","year":"2018","unstructured":"Jensen IJ, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14(10):e1007405.","journal-title":"PLoS Pathog"},{"issue":"4","key":"5099_CR21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-291X(03)01482-7","volume":"308","author":"G Roth","year":"2003","unstructured":"Roth G, et al. Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun. 2003;308(4):840\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"5099_CR22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1189\/jlb.5MR0114-067R","volume":"96","author":"J Cabrera-Perez","year":"2014","unstructured":"Cabrera-Perez J, et al. Impact of sepsis on CD4 T cell immunity. J Leukoc Biol. 2014;96(5):767\u201377.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"5099_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/SHK.0000000000002284","volume":"61","author":"D Adigbli","year":"2024","unstructured":"Adigbli D, Shock, et al. Early persistent lymphopenia and risk of death in critically ill patients with and without sepsis. Shock. 2024;61(2):197\u2013203.","journal-title":"Shock"},{"issue":"2","key":"5099_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5099_CR25","first-page":"56","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"issue":"1","key":"5099_CR26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest. 2016;126(1):23\u201331.","journal-title":"J Clin Invest"},{"issue":"5","key":"5099_CR27","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.166.5.3019","volume":"166","author":"LA Geiselhart","year":"2001","unstructured":"Geiselhart LA, et al. IL-7 administration alters the CD4: CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol. 2001;166(5):3019\u201327.","journal-title":"J Immunol"},{"issue":"5","key":"5099_CR28","doi-asserted-by":"crossref","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","volume":"3","author":"B Francois","year":"2018","unstructured":"Francois B, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3(5):e98960.","journal-title":"JCI Insight"},{"issue":"1","key":"5099_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","volume":"13","author":"T Daix","year":"2023","unstructured":"Daix T, et al. Intravenously administered interleukin-7 to reverse Lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial. Ann Intensiv Care. 2023;13(1):17.","journal-title":"Ann Intensiv Care"},{"issue":"3","key":"5099_CR30","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.0902307","volume":"184","author":"S Inoue","year":"2010","unstructured":"Inoue S, et al. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol. 2010;184(3):1401\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"5099_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0022-4804(79)90021-0","volume":"26","author":"RT Lewis","year":"1979","unstructured":"Lewis RT, Klein H. Risk factors in postoperative sepsis: significance of preoperative lymphocytopenia. J Surg Res. 1979;26(4):365\u201371.","journal-title":"J Surg Res"},{"issue":"6","key":"5099_CR32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00005373-199312000-00007","volume":"35","author":"WG Cheadle","year":"1993","unstructured":"Cheadle WG, et al. Lymphocyte subset responses to trauma and sepsis. J Trauma Acute Care Surg. 1993;35(6):844\u20139.","journal-title":"J Trauma Acute Care Surg"},{"issue":"7","key":"5099_CR33","first-page":"493","volume":"161","author":"R Gennari","year":"1995","unstructured":"Gennari R, et al. Alterations in lymphocyte subsets as prognosticators of postoperative infections. Eur J Surg = Acta Chir. 1995;161(7):493\u20139.","journal-title":"Eur J Surg = Acta Chir"},{"issue":"8","key":"5099_CR34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00003246-199708000-00015","volume":"25","author":"RS Hotchkiss","year":"1997","unstructured":"Hotchkiss RS, et al. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med. 1997;25(8):1298\u2013307.","journal-title":"Crit Care Med"},{"issue":"7","key":"5099_CR35","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.162.7.4148","volume":"162","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss RS, et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in Sepsis. J Immunol. 1999;162(7):4148\u201356.","journal-title":"J Immunol"},{"issue":"25","key":"5099_CR36","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1073\/pnas.96.25.14541","volume":"96","author":"RS Hotchkiss","year":"1999","unstructured":"Hotchkiss RS, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA. 1999;96(25):14541\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"5099_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc10112","volume":"15","author":"C Guignant","year":"2011","unstructured":"Guignant C, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. 2011;15(2):1\u201311.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00024382-200212000-00001","volume":"18","author":"Y Le Tulzo","year":"2002","unstructured":"Le Tulzo Y, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002;18(6):487\u201394.","journal-title":"Shock"},{"issue":"1","key":"5099_CR39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/CCM.0b013e3182657948","volume":"41","author":"F Venet","year":"2013","unstructured":"Venet F, et al. Decreased T-cell repertoire diversity in sepsis: a preliminary study. Crit Care Med. 2013;41(1):111\u20139.","journal-title":"Crit Care Med"},{"issue":"3","key":"5099_CR40","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/CCM.0b013e318274645f","volume":"41","author":"S Inoue","year":"2013","unstructured":"Inoue S, et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care Med. 2013;41(3):810\u20139.","journal-title":"Crit Care Med"},{"issue":"6","key":"5099_CR41","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","volume":"174","author":"K Felmet","year":"2005","unstructured":"Felmet K, et al. Prolonged Lymphopenia, lymphoid depletion, and Hypoprolactinemia in children with nosocomial Sepsis and multiple organ failure. J Immunol. 2005;174(6):3765\u201372.","journal-title":"J Immunol"},{"issue":"3","key":"5099_CR42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1189\/jlb.0808491","volume":"85","author":"J Unsinger","year":"2009","unstructured":"Unsinger J, et al. Differential Lymphopenia-induced homeostatic proliferation for CD4\u2009+\u2009and CD8\u2009+\u2009T cells following septic injury. J Leukoc Biol. 2009;85(3):382\u201390.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"5099_CR43","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"5099_CR44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"5099_CR45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ebiom.2017.09.023","volume":"24","author":"JF Bermejo-Martin","year":"2017","unstructured":"Bermejo-Martin JF, et al. Lymphopenic community acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality. EBioMedicine. 2017;24:231\u20136.","journal-title":"EBioMedicine"},{"issue":"1","key":"5099_CR46","first-page":"e14","volume":"7","author":"M Sheikh","year":"2019","unstructured":"Sheikh M, Vahedi H, et al. Association of Lymphopenia with short term outcomes of sepsis patients; a brief report. Arch Acad Emerg Med. 2019;7(1):e14.","journal-title":"Arch Acad Emerg Med"},{"issue":"6","key":"5099_CR47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/jcm8060843","volume":"8","author":"A Ceccato","year":"2019","unstructured":"Ceccato A, et al. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia. J Clin Med. 2019;8(6):843.","journal-title":"J Clin Med"},{"issue":"6","key":"5099_CR48","doi-asserted-by":"crossref","first-page":"e20200678","DOI":"10.1084\/jem.20200678","volume":"217","author":"SA Vardhana","year":"2020","unstructured":"Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020;217(6):e20200678.","journal-title":"J Exp Med"},{"issue":"11","key":"5099_CR49","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"issue":"9","key":"5099_CR50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/jcp.2004.017335","volume":"57","author":"DH Wyllie","year":"2004","unstructured":"Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol. 2004;57(9):950\u20135.","journal-title":"J Clin Pathol"},{"issue":"5","key":"5099_CR51","doi-asserted-by":"crossref","first-page":"R192","DOI":"10.1186\/cc9309","volume":"14","author":"CP de Jager","year":"2010","unstructured":"de Jager CP, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-017-0304-3","volume":"7","author":"V Zorio","year":"2017","unstructured":"Zorio V, et al. Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge. Ann Intensiv Care. 2017;7(1):80.","journal-title":"Ann Intensiv Care"},{"issue":"3","key":"5099_CR53","first-page":"148","volume":"26","author":"HL Liu","year":"2014","unstructured":"Liu HL, Liu GH, Tian ZX. Changes in blood lymphocytes in sepsis patients. Chin Crit Care Med. 2014;26(3):148\u201352.","journal-title":"Chin Crit Care Med"},{"issue":"6","key":"5099_CR54","doi-asserted-by":"crossref","first-page":"e98819","DOI":"10.1371\/journal.pone.0098819","volume":"9","author":"AH Walton","year":"2014","unstructured":"Walton AH, et al. Reactivation of multiple viruses in patients with sepsis. PLoS ONE. 2014;9(6):e98819.","journal-title":"PLoS ONE"},{"issue":"11","key":"5099_CR55","doi-asserted-by":"crossref","first-page":"e1002685","DOI":"10.1371\/journal.pmed.1002685","volume":"15","author":"M Warny","year":"2018","unstructured":"Warny M, et al. Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLoS Med. 2018;15(11):e1002685.","journal-title":"PLoS Med"},{"key":"5099_CR56","unstructured":"Meri RJV, et al. Persistent lymphocytopenia does not increase nosocomial infection risk in the ICU. medRxiv; 2020."},{"issue":"1","key":"5099_CR57","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec R. Ratio of neutrophil to lymphocyte counts\u2013rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5\u201314.","journal-title":"Bratisl Lek Listy"},{"key":"5099_CR58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13054-015-1144-x","volume":"19","author":"F Rich\u00e9","year":"2015","unstructured":"Rich\u00e9 F, et al. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015;19:439.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR59","doi-asserted-by":"crossref","first-page":"e0179050","DOI":"10.1371\/journal.pone.0179050","volume":"12","author":"X Li","year":"2017","unstructured":"Li X, et al. Interleukin-10\/lymphocyte ratio predicts mortality in severe septic patients. PLoS ONE. 2017;12(6):e0179050.","journal-title":"PLoS ONE"},{"issue":"5","key":"5099_CR60","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","volume":"47","author":"RS Hotchkiss","year":"2019","unstructured":"Hotchkiss RS, et al. Immune checkpoint inhibition in sepsis: a phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 antibody (BMS-936559. Critic Care Med. 2019;47(5):632\u201342.","journal-title":"Critic Care Med"},{"issue":"3","key":"5099_CR61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.chest.2018.03.058","volume":"154","author":"T Daix","year":"2018","unstructured":"Daix T, et al. Multicentric standardized Flow cytometry routine assessment of patients with sepsis to predict clinical worsening. Chest. 2018;154(3):617\u201327.","journal-title":"Chest"},{"issue":"3","key":"5099_CR62","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/cc12750","volume":"17","author":"J Monserrat","year":"2013","unstructured":"Monserrat J, et al. Early alterations of B cells in patients with septic shock. Crit Care. 2013;17(3):R105.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR63","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/cc11157","volume":"16","author":"DS Heffernan","year":"2012","unstructured":"Heffernan DS, et al. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care. 2012;16(1):R12.","journal-title":"Crit Care"},{"issue":"9","key":"5099_CR64","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1097\/CCM.0000000000000344","volume":"42","author":"E Gu\u00e9rin","year":"2014","unstructured":"Gu\u00e9rin E, et al. Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration*. Crit Care Med. 2014;42(9):2007\u201318.","journal-title":"Crit Care Med"},{"key":"5099_CR65","doi-asserted-by":"crossref","first-page":"108452","DOI":"10.1016\/j.intimp.2021.108452","volume":"104","author":"M Malavika","year":"2022","unstructured":"Malavika M, et al. Role of myeloid derived suppressor cells in sepsis. Int Immunopharmacol. 2022;104:108452.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5099_CR66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jinf.2019.04.006","volume":"78","author":"R M\u00e9ndez","year":"2019","unstructured":"M\u00e9ndez R, et al. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Infect. 2019;78(6):423\u201331.","journal-title":"J Infect"},{"issue":"4","key":"5099_CR67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4046\/trd.2001.50.4.437","volume":"50","author":"JK Hwang","year":"2001","unstructured":"Hwang JK, et al. Prospective study of the immunologic factors affecting the prognosis of severe community-acquired pneumonia. Tuberc Respir Dis. 2001;50(4):437\u201349.","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"5099_CR68","doi-asserted-by":"crossref","first-page":"e000152","DOI":"10.1136\/bmjresp-2016-000152","volume":"3","author":"MC de la Torre","year":"2016","unstructured":"de la Torre MC, et al. Serum levels of immunoglobulins and severity of community-acquired pneumonia. BMJ open Respiratory Res. 2016;3(1):e000152.","journal-title":"BMJ open Respiratory Res"},{"issue":"1","key":"5099_CR69","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1038\/s41598-024-63902-2","volume":"14","author":"P Sobia","year":"2024","unstructured":"Sobia P, et al. Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trial. Sci Rep. 2024;14(1):13499.","journal-title":"Sci Rep"},{"issue":"4","key":"5099_CR70","doi-asserted-by":"crossref","first-page":"L590","DOI":"10.1152\/ajplung.00359.2020","volume":"320","author":"F Husain-Syed","year":"2021","unstructured":"Husain-Syed F, et al. Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19. Am J Physiology-Lung Cell Mol Physiol. 2021;320(4):L590\u20139.","journal-title":"Am J Physiology-Lung Cell Mol Physiol"},{"issue":"3","key":"5099_CR71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/jcm8030353","volume":"8","author":"P Hohlstein","year":"2019","unstructured":"Hohlstein P, et al. Prognostic relevance of altered lymphocyte subpopulations in critical illness and sepsis. J Clin Med. 2019;8(3):353.","journal-title":"J Clin Med"},{"issue":"3","key":"5099_CR72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/0972-5229.117054","volume":"17","author":"KM Sundar","year":"2013","unstructured":"Sundar KM, Sires M. Sepsis induced immunosuppression: implications for secondary infections and complications. Indian J Crit Care Med. 2013;17(3):162\u20139.","journal-title":"Indian J Crit Care Med"},{"issue":"4","key":"5099_CR73","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/etm.2016.3071","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, et al. Clinical application: restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis. Exp Ther Med. 2016;11(4):1159\u201367.","journal-title":"Exp Ther Med"},{"issue":"12","key":"5099_CR74","doi-asserted-by":"crossref","first-page":"e115094","DOI":"10.1371\/journal.pone.0115094","volume":"9","author":"R Markwart","year":"2014","unstructured":"Markwart R, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of na\u00efve T-cells but no enduring cell-autonomous defects in T-cell function. PLoS ONE. 2014;9(12):e115094.","journal-title":"PLoS ONE"},{"issue":"1","key":"5099_CR75","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/cc7731","volume":"13","author":"J Monserrat","year":"2009","unstructured":"Monserrat J, et al. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care. 2009;13(1):R26.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jir.2014.0069","volume":"35","author":"YY Luan","year":"2015","unstructured":"Luan YY, et al. Insights into the apoptotic death of immune cells in sepsis. J Interferon Cytokine Res. 2015;35(1):17\u201322.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"5099_CR77","doi-asserted-by":"crossref","first-page":"0169653","DOI":"10.1371\/journal.pone.0169653","volume":"12","author":"A Tomino","year":"2017","unstructured":"Tomino A, et al. Increased PD-1 expression and altered T cell repertoire diversity predict mortality in patients with septic shock: a preliminary study. PLoS ONE. 2017;12(1):0169653.","journal-title":"PLoS ONE"},{"issue":"3","key":"5099_CR78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20040638","volume":"200","author":"D Meyer-Olson","year":"2004","unstructured":"Meyer-Olson D, et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med. 2004;200(3):307\u201319.","journal-title":"J Exp Med"},{"issue":"3","key":"5099_CR79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SHK.0000000000000981","volume":"49","author":"JA Stortz","year":"2018","unstructured":"Stortz JA, et al. Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis. Shock. 2018;49(3):249\u201358.","journal-title":"Shock"},{"key":"5099_CR80","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3389\/fimmu.2020.01918","volume":"11","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, et al. The critical roles and mechanisms of immune cell death in sepsis. Front Immunol. 2020;11:1918\u20131918.","journal-title":"Front Immunol"},{"key":"5099_CR81","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3389\/fimmu.2018.02446","volume":"9","author":"SJ Denstaedt","year":"2018","unstructured":"Denstaedt SJ, Singer BH, Standiford TJ. Sepsis and nosocomial infection: patient characteristics, mechanisms, and modulation. Front Immunol. 2018;9:2446.","journal-title":"Front Immunol"},{"issue":"8","key":"5099_CR82","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.174.8.5110","volume":"174","author":"RS Hotchkiss","year":"2005","unstructured":"Hotchkiss RS, et al. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005;174(8):5110\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"5099_CR83","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000135631","volume":"41","author":"T Ma","year":"2008","unstructured":"Ma T, et al. The endoplasmic reticulum stress-mediated apoptosis signal pathway is involved in sepsis-induced abnormal lymphocyte apoptosis. Eur Surg Res. 2008;41(2):219\u201325.","journal-title":"Eur Surg Res"},{"issue":"9","key":"5099_CR84","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1164\/rccm.200604-546OC","volume":"174","author":"A Sarkar","year":"2006","unstructured":"Sarkar A, et al. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med. 2006;174(9):1003\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5099_CR85","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/cc7088","volume":"12","author":"SU Weber","year":"2008","unstructured":"Weber SU, et al. Induction of Bim and bid gene expression during accelerated apoptosis in severe sepsis. Crit Care. 2008;12(5):R128.","journal-title":"Crit Care"},{"issue":"4","key":"5099_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00024382-199704000-00002","volume":"7","author":"M Hiramatsu","year":"1997","unstructured":"Hiramatsu M, et al. Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock. 1997;7(4):247\u201353.","journal-title":"Shock"},{"issue":"5","key":"5099_CR87","doi-asserted-by":"crossref","first-page":"G812","DOI":"10.1152\/ajpgi.2001.280.5.G812","volume":"280","author":"CS Chung","year":"2001","unstructured":"Chung CS, et al. Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. Am J Physiol Gastrointest Liver Physiol. 2001;280(5):G812\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"5099_CR88","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-065X.2010.00917.x","volume":"236","author":"AL Snow","year":"2010","unstructured":"Snow AL, et al. The power and the promise of restimulation-induced cell death in human immune diseases. Immunol Rev. 2010;236(1):68\u201382.","journal-title":"Immunol Rev"},{"issue":"7","key":"5099_CR89","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri2115","volume":"7","author":"PH Krammer","year":"2007","unstructured":"Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol. 2007;7(7):532\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5099_CR90","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.4049\/jimmunol.169.4.1822","volume":"169","author":"EL Tham","year":"2002","unstructured":"Tham EL, Mescher MF. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). J Immunol. 2002;169(4):1822\u20138.","journal-title":"J Immunol"},{"issue":"4","key":"5099_CR91","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1073\/pnas.97.4.1707","volume":"97","author":"I Suzuki","year":"2000","unstructured":"Suzuki I, Fink PJ. The dual functions of fas ligand in the regulation of peripheral CD8\u2009+\u2009and CD4\u2009+\u2009T cells. Proc Natl Acad Sci. 2000;97(4):1707\u201312.","journal-title":"Proc Natl Acad Sci"},{"issue":"6547","key":"5099_CR92","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/377348a0","volume":"377","author":"L Zheng","year":"1995","unstructured":"Zheng L, et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 1995;377(6547):348\u201351.","journal-title":"Nature"},{"issue":"7","key":"5099_CR93","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.4049\/jimmunol.164.7.3675","volume":"164","author":"RS Hotchkiss","year":"2000","unstructured":"Hotchkiss RS, et al. 53-dependent and-independent pathways of apoptotic cell death in sepsis. J Immunol. 2000;164(7):3675\u201380.","journal-title":"J Immunol"},{"issue":"6","key":"5099_CR94","doi-asserted-by":"crossref","first-page":"e0178946","DOI":"10.1371\/journal.pone.0178946","volume":"12","author":"TM Merz","year":"2017","unstructured":"Merz TM, et al. Mitochondrial function of immune cells in septic shock: a prospective observational cohort study. PLoS ONE. 2017;12(6):e0178946.","journal-title":"PLoS ONE"},{"issue":"2","key":"5099_CR95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.1601999","volume":"199","author":"B Larkin","year":"2017","unstructured":"Larkin B, et al. Cutting edge: activation of STING in T cells induces type I IFN responses and cell death. J Immunol. 2017;199(2):397\u2013402.","journal-title":"J Immunol"},{"issue":"39","key":"5099_CR96","doi-asserted-by":"crossref","first-page":"eabc5447","DOI":"10.1126\/sciadv.abc5447","volume":"6","author":"J Long","year":"2020","unstructured":"Long J, et al. Notch signaling protects CD4 T cells from STING-mediated apoptosis during acute systemic inflammation. Sci Adv. 2020;6(39):eabc5447.","journal-title":"Sci Adv"},{"issue":"3\u20134","key":"5099_CR97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2119\/molmed.2010.00178","volume":"17","author":"AG Cuenca","year":"2011","unstructured":"Cuenca AG, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med. 2011;17(3\u20134):281\u201392.","journal-title":"Mol Med"},{"issue":"2","key":"5099_CR98","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","volume":"160","author":"D Annane","year":"1999","unstructured":"Annane D, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160(2):458\u201365.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"5099_CR99","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1536\/jhj.41.385","volume":"41","author":"DP Cioca","year":"2000","unstructured":"Cioca DP, Watanabe N, Isobe M. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn Heart J. 2000;41(3):385\u201398.","journal-title":"Jpn Heart J"},{"issue":"3","key":"5099_CR100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2009.01.002","volume":"15","author":"Y-C Hsieh","year":"2009","unstructured":"Hsieh Y-C, Athar M, Chaudry IH. When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol Med. 2009;15(3):129\u201338.","journal-title":"Trends Mol Med"},{"issue":"1","key":"5099_CR101","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/CCM.0000000000002016","volume":"45","author":"T Oami","year":"2017","unstructured":"Oami T, et al. Suppression of T cell autophagy results in decreased viability and function of T cells through accelerated apoptosis in a murine sepsis model. Crit Care Med. 2017;45(1):e77\u201385.","journal-title":"Crit Care Med"},{"issue":"7","key":"5099_CR102","doi-asserted-by":"crossref","first-page":"e102066","DOI":"10.1371\/journal.pone.0102066","volume":"9","author":"C-W Lin","year":"2014","unstructured":"Lin C-W, et al. T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS ONE. 2014;9(7):e102066.","journal-title":"PLoS ONE"},{"issue":"4","key":"5099_CR103","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20110251","volume":"208","author":"IL Ch\u2019","year":"2011","unstructured":"Ch\u2019 IL, et al. Mechanisms of necroptosis in T cells. J Exp Med. 2011;208(4):633\u201341.","journal-title":"J Exp Med"},{"issue":"4","key":"5099_CR104","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212(4):555\u201368.","journal-title":"J Exp Med"},{"issue":"2","key":"5099_CR105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.20171976","volume":"216","author":"CE Faliti","year":"2019","unstructured":"Faliti CE, et al. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus. J Exp Med. 2019;216(2):317\u201336.","journal-title":"J Exp Med"},{"issue":"45","key":"5099_CR106","doi-asserted-by":"crossref","first-page":"eaay5552","DOI":"10.1126\/sciimmunol.aay5552","volume":"5","author":"M K\u00fcnzli","year":"2020","unstructured":"K\u00fcnzli M, et al. Long-lived T follicular helper cells retain plasticity and help sustain humoral immunity. Sci Immunol. 2020;5(45):eaay5552.","journal-title":"Sci Immunol"},{"issue":"19","key":"5099_CR107","doi-asserted-by":"crossref","first-page":"e105071","DOI":"10.15252\/embj.2020105071","volume":"39","author":"A Linder","year":"2020","unstructured":"Linder A, et al. CARD8 inflammasome activation triggers pyroptosis in human T cells. EMBO J. 2020;39(19):e105071.","journal-title":"EMBO J"},{"issue":"8","key":"5099_CR108","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-020-02865-4","volume":"11","author":"DC Johnson","year":"2020","unstructured":"Johnson DC, et al. DPP8\/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes. Cell Death Dis. 2020;11(8):628.","journal-title":"Cell Death Dis"},{"issue":"3","key":"5099_CR109","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/cc11376","volume":"16","author":"A Gouel-Ch\u00e9ron","year":"2012","unstructured":"Gouel-Ch\u00e9ron A, et al. CD4\u2009+\u2009T-lymphocyte alterations in trauma patients. Crit Care. 2012;16(3):432.","journal-title":"Crit Care"},{"issue":"10","key":"5099_CR110","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1348-0421.2011.00373.x","volume":"55","author":"X Chen","year":"2011","unstructured":"Chen X, Ye J, Ye J. Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock. Microbiol Immunol. 2011;55(10):736\u201342.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"5099_CR111","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1401711","volume":"194","author":"J Cabrera-Perez","year":"2015","unstructured":"Cabrera-Perez J, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194(4):1609\u201320.","journal-title":"J Immunol"},{"issue":"2","key":"5099_CR112","doi-asserted-by":"crossref","first-page":"e0211716","DOI":"10.1371\/journal.pone.0211716","volume":"14","author":"C Ammer-Herrmenau","year":"2019","unstructured":"Ammer-Herrmenau C, et al. Sepsis induces long-lasting impairments in CD4\u2009+\u2009T-cell responses despite rapid numerical recovery of T-lymphocyte populations. PLoS ONE. 2019;14(2):e0211716.","journal-title":"PLoS ONE"},{"issue":"8","key":"5099_CR113","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nri853","volume":"2","author":"SC Jameson","year":"2002","unstructured":"Jameson SC. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol. 2002;2(8):547\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5099_CR114","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.4049\/jimmunol.1000109","volume":"184","author":"LD Johnson","year":"2010","unstructured":"Johnson LD, Jameson SC. Self-specific CD8\u2009+\u2009T cells maintain a semi-naive state following lymphopenia-induced proliferation. J Immunol. 2010;184(10):5604\u201311.","journal-title":"J Immunol"},{"issue":"10","key":"5099_CR115","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.4049\/jimmunol.152.10.5014","volume":"152","author":"SD Wang","year":"1994","unstructured":"Wang SD, et al. Sepsis-induced apoptosis of the thymocytes in mice. J Immunol. 1994;152(10):5014\u201321.","journal-title":"J Immunol"},{"issue":"12","key":"5099_CR116","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/stem.2464","volume":"34","author":"Y Kong","year":"2016","unstructured":"Kong Y, et al. Sepsis-induced thymic atrophy is associated with defects in early lymphopoiesis. Stem Cells. 2016;34(12):2902\u201315.","journal-title":"Stem Cells"},{"key":"5099_CR117","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10495-020-01629-x","volume":"25","author":"L Prenek","year":"2020","unstructured":"Prenek L, et al. Regulatory T cells are less sensitive to glucocorticoid hormone induced apoptosis than CD4\u2009+\u2009T cells. Apoptosis. 2020;25:715\u201329.","journal-title":"Apoptosis"},{"issue":"5","key":"5099_CR118","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.0903652","volume":"184","author":"PO Scumpia","year":"2010","unstructured":"Scumpia PO, et al. Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling. J Immunol. 2010;184(5):2247\u201351.","journal-title":"J Immunol"},{"issue":"1","key":"5099_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc9398","volume":"15","author":"Y-Y Zhang","year":"2011","unstructured":"Zhang Y-Y, et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care. 2011;15(1):1\u20139.","journal-title":"Crit Care"},{"key":"5099_CR120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","volume":"20","author":"A Spec","year":"2016","unstructured":"Spec A, et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care. 2016;20:15.","journal-title":"Crit Care"},{"issue":"3","key":"5099_CR121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc11404","volume":"16","author":"JS Boomer","year":"2012","unstructured":"Boomer JS, et al. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit Care. 2012;16(3):1\u201314.","journal-title":"Crit Care"},{"issue":"10","key":"5099_CR122","doi-asserted-by":"crossref","first-page":"e134475","DOI":"10.1172\/jci.insight.134475","volume":"5","author":"T Skirecki","year":"2020","unstructured":"Skirecki T, et al. Bone marrow is the preferred site of memory CD4\u2009+\u2009T cell proliferation during recovery from sepsis. JCI Insight. 2020;5(10):e134475.","journal-title":"JCI Insight"},{"issue":"6","key":"5099_CR123","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","volume":"44","author":"A Terashima","year":"2016","unstructured":"Terashima A, et al. Sepsis-Induced osteoblast ablation causes immunodeficiency. Immunity. 2016;44(6):1434\u201343.","journal-title":"Immunity"},{"issue":"5","key":"5099_CR124","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.1202379","volume":"190","author":"SA Condotta","year":"2013","unstructured":"Condotta SA, et al. Sustained and incomplete recovery of naive CD8\u2009+\u2009T cell precursors after sepsis contributes to impaired CD8\u2009+\u2009T cell responses to infection. J Immunol. 2013;190(5):1991\u20132000.","journal-title":"J Immunol"},{"issue":"4","key":"5099_CR125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.192.4.549","volume":"192","author":"BK Cho","year":"2000","unstructured":"Cho BK, et al. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med. 2000;192(4):549\u201356.","journal-title":"J Exp Med"},{"issue":"5","key":"5099_CR126","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.0900641","volume":"183","author":"KP Cheung","year":"2009","unstructured":"Cheung KP, Yang E, Goldrath AW. Memory-like CD8\u2009+\u2009T cells generated during homeostatic proliferation defer to antigen-experienced memory cells. J Immunol. 2009;183(5):3364\u201372.","journal-title":"J Immunol"},{"issue":"4","key":"5099_CR127","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.192.4.557","volume":"192","author":"AW Goldrath","year":"2000","unstructured":"Goldrath AW, Bogatzki LY, Bevan MJ. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med. 2000;192(4):557\u201364.","journal-title":"J Exp Med"},{"issue":"5","key":"5099_CR128","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.4049\/jimmunol.1600940","volume":"197","author":"J Cabrera-Perez","year":"2016","unstructured":"Cabrera-Perez J, et al. Gut microbial membership modulates CD4 T cell reconstitution and function after sepsis. J Immunol. 2016;197(5):1692\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"5099_CR129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4049\/jimmunol.2200676","volume":"210","author":"SJ Moioffer","year":"2023","unstructured":"Moioffer SJ, et al. Inefficient recovery of repeatedly stimulated memory CD8 T cells after polymicrobial sepsis induction leads to changes in memory CD8 T cell pool composition. J Immunol. 2023;210(2):168\u201379.","journal-title":"J Immunol"},{"key":"5099_CR130","doi-asserted-by":"crossref","first-page":"5130463","DOI":"10.1155\/2018\/5130463","volume":"2018","author":"S Nullens","year":"2018","unstructured":"Nullens S, et al. Identifying therapeutic targets for sepsis research: a characterization study of the inflammatory players in the cecal ligation and puncture model. Mediators Inflamm. 2018;2018:5130463.","journal-title":"Mediators Inflamm"},{"issue":"2\u20133","key":"5099_CR131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(96)01535-9","volume":"402","author":"S Ahmad","year":"1997","unstructured":"Ahmad S, et al. Transforming growth factor-beta negatively modulates T-cell responses in sepsis. FEBS Lett. 1997;402(2\u20133):213\u20138.","journal-title":"FEBS Lett"},{"issue":"6","key":"5099_CR132","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992\u20131000. e3.","journal-title":"Cell Host Microbe"},{"issue":"8","key":"5099_CR133","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","volume":"30","author":"X He","year":"2020","unstructured":"He X, Xu C. Immune checkpoint signaling and cancer immunotherapy. Cell Res. 2020;30(8):660\u20139.","journal-title":"Cell Res"},{"issue":"9","key":"5099_CR134","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/13543784.2022.2102477","volume":"31","author":"M Rienzo","year":"2022","unstructured":"Rienzo M, et al. Immune checkpoint inhibitors for the treatment of sepsis:insights from preclinical and clinical development. Expert Opin Investig Drugs. 2022;31(9):885\u201394.","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"5099_CR135","doi-asserted-by":"crossref","first-page":"e0141","DOI":"10.1097\/CCE.0000000000000141","volume":"2","author":"Z Odabasi","year":"2020","unstructured":"Odabasi Z, Cinel I. Consideration of severe coronavirus disease 2019 as viral sepsis and potential use of immune checkpoint inhibitors. Crit Care Explor. 2020;2(6):e0141.","journal-title":"Crit Care Explor"},{"key":"5099_CR136","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3389\/fimmu.2017.01289","volume":"8","author":"KK Ellestad","year":"2017","unstructured":"Ellestad KK, et al. PD-1 controls tonic signaling and lymphopenia-induced proliferation of T lymphocytes. Front Immunol. 2017;8:1289.","journal-title":"Front Immunol"},{"issue":"24","key":"5099_CR137","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.3390\/cells11243958","volume":"11","author":"Z Wang","year":"2022","unstructured":"Wang Z, et al. Inhibition of EZH2 ameliorates sepsis acute lung injury (SALI) and non-small-cell lung cancer (NSCLC) proliferation through the PD-L1 pathway. Cells. 2022;11(24).","journal-title":"Cells"},{"issue":"2","key":"5099_CR138","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/08830185.2021.1884247","volume":"41","author":"YC Liu","year":"2022","unstructured":"Liu YC, Shou ST, Chai YF. Immune checkpoints in sepsis: new hopes and challenges. Int Rev Immunol. 2022;41(2):207\u201316.","journal-title":"Int Rev Immunol"},{"issue":"3","key":"5099_CR139","first-page":"1","volume":"17","author":"K Chang","year":"2013","unstructured":"Chang K, et al. Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis. Crit Care. 2013;17(3):1\u201314.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","volume":"36","author":"S Inoue","year":"2011","unstructured":"Inoue S, et al. Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock. 2011;36(1):38\u201344.","journal-title":"Shock"},{"issue":"2","key":"5099_CR141","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/cei.12401","volume":"178","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, et al. Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression. Clin Exp Immunol. 2014;178(2):279\u201391.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"5099_CR142","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.4049\/jimmunol.1202661","volume":"190","author":"X Yang","year":"2013","unstructured":"Yang X, et al. T cell ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol. 2013;190(5):2068\u201379.","journal-title":"J Immunol"},{"issue":"3","key":"5099_CR143","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1189\/jlb.1211641","volume":"92","author":"NJ Shubin","year":"2012","unstructured":"Shubin NJ, et al. BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction. J Leukoc Biol. 2012;92(3):593\u2013603.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"5099_CR144","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1186\/cc13143","volume":"17","author":"ER Sherwood","year":"2013","unstructured":"Sherwood ER, Hotchkiss RS. BTLA as a biomarker and mediator of sepsis-induced immunosuppression. Crit Care. 2013;17(6):1022.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s10020-018-0036-3","volume":"24","author":"SF Monaghan","year":"2018","unstructured":"Monaghan SF, et al. Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness. Mol Med. 2018;24(1):32.","journal-title":"Mol Med"},{"issue":"6","key":"5099_CR146","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.4049\/jimmunol.172.6.3544","volume":"172","author":"CJ Chen","year":"2004","unstructured":"Chen CJ, Shively JE. The cell-cell adhesion molecule carcinoembryonic antigen-related cellular adhesion molecule 1 inhibits IL-2 production and proliferation in human T cells by association with src homology protein-1 and down-regulates IL-2 receptor. J Immunol. 2004;172(6):3544\u201352.","journal-title":"J Immunol"},{"issue":"7","key":"5099_CR147","doi-asserted-by":"crossref","first-page":"e68294","DOI":"10.1371\/journal.pone.0068294","volume":"8","author":"M van der Flier","year":"2013","unstructured":"van der Flier M, et al. Increased CD4(+) T cell co-inhibitory immune receptor CEACAM1 in neonatal sepsis and soluble-CEACAM1 in meningococcal sepsis: a role in sepsis-associated immune suppression? PLoS ONE. 2013;8(7):e68294.","journal-title":"PLoS ONE"},{"issue":"1","key":"5099_CR148","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.2013006721","volume":"33","author":"SA Condotta","year":"2013","unstructured":"Condotta SA, et al. T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol. 2013;33(1):23\u201340.","journal-title":"Crit Rev Immunol"},{"issue":"4","key":"5099_CR149","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00134-008-1337-8","volume":"35","author":"F Venet","year":"2009","unstructured":"Venet F, et al. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med. 2009;35(4):678\u201386.","journal-title":"Intensive Care Med"},{"issue":"3","key":"5099_CR150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1189\/jlb.0607371","volume":"83","author":"F Venet","year":"2008","unstructured":"Venet F, et al. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol. 2008;83(3):523\u201335.","journal-title":"J Leukoc Biol"},{"key":"5099_CR151","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3389\/fimmu.2020.01299","volume":"11","author":"WS Ruan","year":"2020","unstructured":"Ruan WS, et al. Early activation of myeloid-derived suppressor cells participate in sepsis-induced immune suppression via PD-L1\/PD-1 Axis. Front Immunol. 2020;11:1299.","journal-title":"Front Immunol"},{"key":"5099_CR152","doi-asserted-by":"crossref","first-page":"458626","DOI":"10.1155\/2015\/458626","volume":"2015","author":"X Ruan","year":"2015","unstructured":"Ruan X, et al. Anti-HMGB1 monoclonal antibody ameliorates immunosuppression after peripheral tissue trauma: attenuated T-lymphocyte response and increased splenic CD11b (+) Gr-1 (+) myeloid-derived suppressor cells require HMGB1. Mediators Inflamm. 2015;2015:458626.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"5099_CR153","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/cc14003","volume":"18","author":"CJ Darcy","year":"2014","unstructured":"Darcy CJ, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care. 2014;18(4):R163.","journal-title":"Crit Care"},{"issue":"4","key":"5099_CR154","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","volume":"68","author":"L Cassetta","year":"2019","unstructured":"Cassetta L, et al. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunol Immunother. 2019;68(4):687\u201397.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"5099_CR155","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.1700127","volume":"199","author":"F Venet","year":"2017","unstructured":"Venet F, et al. IL-7 restores T lymphocyte immunometabolic failure in septic shock patients through mTOR activation. J Immunol. 2017;199(5):1606\u201315.","journal-title":"J Immunol"},{"issue":"7","key":"5099_CR156","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1210\/clinem\/dgab148","volume":"106","author":"I Grondman","year":"2021","unstructured":"Grondman I, et al. The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19. J Clin Endocrinol Metab. 2021;106(7):1994\u20132009.","journal-title":"J Clin Endocrinol Metab"},{"key":"5099_CR157","doi-asserted-by":"crossref","first-page":"961744","DOI":"10.3389\/fendo.2022.961744","volume":"13","author":"S Incerpi","year":"2022","unstructured":"Incerpi S, et al. Extranuclear effects of thyroid hormones and analogs during development: an old mechanism with emerging roles. Front Endocrinol (Lausanne). 2022;13:961744.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5099_CR158","doi-asserted-by":"crossref","first-page":"C977","DOI":"10.1152\/ajpcell.00116.2009","volume":"296","author":"M Bhargava","year":"2009","unstructured":"Bhargava M, Lei J, Ingbar DH. Nongenomic actions of L-thyroxine and 3,5,3\u2019-triiodo-L-thyronine. Focus on L-Thyroxine vs. 3,5,3\u2019-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol. 2009;296(5):C977-9.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"5099_CR159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc13941","volume":"18","author":"S Inoue","year":"2014","unstructured":"Inoue S, et al. Persistent inflammation and T cell exhaustion in severe sepsis in the elderly. Crit Care. 2014;18(3):1\u201313.","journal-title":"Crit Care"},{"issue":"1","key":"5099_CR160","first-page":"56","volume":"8","author":"PJ Fraker","year":"2004","unstructured":"Fraker PJ, Lill-Elghanian DA. The many roles of apoptosis in immunity as modified by aging and nutritional status. J Nutr Health Aging. 2004;8(1):56\u201363.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"5099_CR161","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12810","volume":"185","author":"J Pagel","year":"2016","unstructured":"Pagel J, et al. Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis. Clin Exp Immunol. 2016;185(2):219\u201327.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"5099_CR162","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc9031","volume":"14","author":"C Gogos","year":"2010","unstructured":"Gogos C, et al. Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection. Crit Care. 2010;14(3):R96.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR163","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1445-5994.2006.01076.x","volume":"36","author":"CA Hawkins","year":"2006","unstructured":"Hawkins CA, et al. Profound lymphopenia and bacteraemia. Intern Med J. 2006;36(6):385\u20138.","journal-title":"Intern Med J"},{"issue":"3","key":"5099_CR164","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1469-0691.2003.00518.x","volume":"9","author":"M Holub","year":"2003","unstructured":"Holub M, et al. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect. 2003;9(3):202\u201311.","journal-title":"Clin Microbiol Infect"},{"key":"5099_CR165","doi-asserted-by":"crossref","first-page":"e31733","DOI":"10.1016\/j.heliyon.2024.e31733","volume":"10","author":"W Yang","year":"2024","unstructured":"Yang W, et al. Prolonged lymphopenia and prognoses among inpatients with different respiratory virus infections: a retrospective cohort study. Heliyon. 2024;10:e31733.","journal-title":"Heliyon"},{"issue":"1","key":"5099_CR166","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s13054-020-03398-0","volume":"24","author":"JF Bermejo-Martin","year":"2020","unstructured":"Bermejo-Martin JF, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020;24(1):691.","journal-title":"Crit Care"},{"issue":"12","key":"5099_CR167","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19(12):e422\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"5099_CR168","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/84219","volume":"2","author":"B Moser","year":"2001","unstructured":"Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2(2):123\u20138.","journal-title":"Nat Immunol"},{"issue":"22","key":"5099_CR169","doi-asserted-by":"crossref","first-page":"447","DOI":"10.21037\/atm.2017.09.21","volume":"5","author":"T Ryan","year":"2017","unstructured":"Ryan T, Coakley JD, Martin-Loeches I. Defects in innate and adaptive immunity in patients with sepsis and health care associated infection. Ann Transl Med. 2017;5(22):447.","journal-title":"Ann Transl Med"},{"key":"5099_CR170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/bs.ai.2017.03.001","volume":"135","author":"CE Gregor","year":"2017","unstructured":"Gregor CE, et al. Chemokine-driven CD4(+) T cell homing: new concepts and recent advances. Adv Immunol. 2017;135:119\u201381.","journal-title":"Adv Immunol"},{"issue":"2","key":"5099_CR171","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/ijms18020388","volume":"18","author":"KY Lee","year":"2017","unstructured":"Lee KY. Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. Int J Mol Sci. 2017;18(2):388.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5099_CR172","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2008-11-191288","volume":"114","author":"S Beq","year":"2009","unstructured":"Beq S, et al. Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques. Blood. 2009;114(4):816\u201325.","journal-title":"Blood"},{"issue":"4","key":"5099_CR173","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood-2009-04-217091","volume":"114","author":"I Sereti","year":"2009","unstructured":"Sereti I. Where have all the T cells gone? Blood. 2009;114(4):751\u20132.","journal-title":"Blood"},{"issue":"3","key":"5099_CR174","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.humimm.2013.11.004","volume":"75","author":"DS Heffernan","year":"2014","unstructured":"Heffernan DS, et al. A divergent response of innate regulatory T-cells to sepsis in humans: circulating invariant natural killer T-cells are preserved. Hum Immunol. 2014;75(3):277\u201382.","journal-title":"Hum Immunol"},{"issue":"2","key":"5099_CR175","doi-asserted-by":"crossref","first-page":"e0148452","DOI":"10.1371\/journal.pone.0148452","volume":"11","author":"NK Patil","year":"2016","unstructured":"Patil NK, et al. IL-15 superagonist expands mCD8\u2009+\u2009T, NK and NKT Cells after burn injury but fails to improve outcome during burn wound infection. PLoS ONE. 2016;11(2):e0148452.","journal-title":"PLoS ONE"},{"issue":"2","key":"5099_CR176","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00134-013-3163-x","volume":"40","author":"D Grimaldi","year":"2014","unstructured":"Grimaldi D, et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2014;40(2):192\u2013201.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5099_CR177","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archsurg.133.11.1213","volume":"133","author":"C-S Chung","year":"1998","unstructured":"Chung C-S, et al. Is fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg. 1998;133(11):1213\u201320.","journal-title":"Arch Surg"},{"issue":"2","key":"5099_CR178","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SHK.0b013e318194bcee","volume":"32","author":"P Brahmamdam","year":"2009","unstructured":"Brahmamdam P, et al. Targeted delivery of siRNA to cell death proteins in sepsis. Shock. 2009;32(2):131\u20139.","journal-title":"Shock"},{"issue":"6","key":"5099_CR179","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/82741","volume":"1","author":"RS Hotchkiss","year":"2000","unstructured":"Hotchkiss RS, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol. 2000;1(6):496\u2013501.","journal-title":"Nat Immunol"},{"issue":"2","key":"5099_CR180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1096\/fj.07-8283com","volume":"22","author":"JE McDunn","year":"2008","unstructured":"McDunn JE, et al. Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis. Faseb J. 2008;22(2):561\u20138.","journal-title":"Faseb J"},{"issue":"11","key":"5099_CR181","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1096\/fj.03-1230com","volume":"18","author":"JG Weaver","year":"2004","unstructured":"Weaver JG, et al. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. Faseb J. 2004;18(11):1185\u201391.","journal-title":"Faseb J"},{"issue":"11","key":"5099_CR182","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms18112413","volume":"18","author":"NK Patil","year":"2017","unstructured":"Patil NK, et al. Targeting immune cell checkpoints during sepsis. Int J Mol Sci. 2017;18(11):2413.","journal-title":"Int J Mol Sci"},{"key":"5099_CR183","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3389\/fimmu.2018.01926","volume":"9","author":"AMP van Ton","year":"2018","unstructured":"van Ton AMP, et al. Precision immunotherapy for sepsis. Front Immunol. 2018;9:1926\u20131926.","journal-title":"Front Immunol"},{"issue":"5","key":"5099_CR184","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.1302160","volume":"192","author":"M Aziz","year":"2014","unstructured":"Aziz M, et al. Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis. J Immunol. 2014;192(5):2305\u201314.","journal-title":"J Immunol"},{"issue":"1","key":"5099_CR185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.intimp.2014.08.015","volume":"23","author":"JC Andreu-Ballester","year":"2014","unstructured":"Andreu-Ballester JC, et al. Deficit of interleukin 7 in septic patients. Int Immunopharmacol. 2014;23(1):73\u20136.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"5099_CR186","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0903151","volume":"184","author":"J Unsinger","year":"2010","unstructured":"Unsinger J, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol. 2010;184(7):3768\u201379.","journal-title":"J Immunol"},{"issue":"10","key":"5099_CR187","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.4049\/jimmunol.1202062","volume":"189","author":"F Venet","year":"2012","unstructured":"Venet F, et al. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012;189(10):5073\u201381.","journal-title":"J Immunol"},{"issue":"1","key":"5099_CR188","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13613-022-00982-1","volume":"12","author":"F Bidar","year":"2022","unstructured":"Bidar F, et al. Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients. Ann Intensive Care. 2022;12(1):21.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"5099_CR189","doi-asserted-by":"crossref","first-page":"2232247","DOI":"10.1080\/21645515.2023.2232247","volume":"19","author":"C Marton","year":"2023","unstructured":"Marton C, et al. IL-7 producing immunotherapy improves ex vivo T cell functions of immunosenescent patients, especially post hip fracture. Hum Vaccin Immunother. 2023;19(2):2232247.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"5099_CR190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc13176","volume":"18","author":"K Chang","year":"2014","unstructured":"Chang K, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014;18(1):1\u201315.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR191","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/cc9354","volume":"14","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 2010;14(6):R220.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR192","doi-asserted-by":"crossref","first-page":"R276","DOI":"10.1186\/cc13131","volume":"17","author":"NJ Shubin","year":"2013","unstructured":"Shubin NJ, et al. B and T lymphocyte attenuator expression on CD4\u2009+\u2009T-cells associates with sepsis and subsequent infections in ICU patients. Crit Care. 2013;17(6):R276.","journal-title":"Crit Care"},{"issue":"6","key":"5099_CR193","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.4049\/jimmunol.1700375","volume":"199","author":"CW Chen","year":"2017","unstructured":"Chen CW, et al. Cutting edge: 2B4-mediated coinhibition of CD4(+) T cells underlies mortality in experimental Sepsis. J Immunol. 2017;199(6):1961\u20136.","journal-title":"J Immunol"},{"issue":"9","key":"5099_CR194","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","volume":"42","author":"DT Andreis","year":"2016","unstructured":"Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-hyde conundrum. Intensive Care Med. 2016;42(9):1387\u201397.","journal-title":"Intensive Care Med"},{"key":"5099_CR195","first-page":"8157482","volume":"2019","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, et al. Beta-blocker therapy preserves normal splenic t-lymphocyte numbers reduced in proportion to sepsis severity in a sepsis model. Crit Care Res Pract. 2019;2019:8157482.","journal-title":"Crit Care Res Pract"},{"issue":"9","key":"5099_CR196","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1097\/CCM.0000000000005503","volume":"50","author":"M Durand","year":"2022","unstructured":"Durand M, et al. The beta 1 -adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory T-Cell inhibitory function. Crit Care Med. 2022;50(9):e707-18.","journal-title":"Crit Care Med"},{"issue":"3","key":"5099_CR197","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jointm.2022.01.004","volume":"2","author":"M Lescroart","year":"2022","unstructured":"Lescroart M, et al. Beta-blockers in septic shock: what is new? J Intensive Med. 2022;2(3):150\u20135.","journal-title":"J Intensive Med"},{"issue":"6","key":"5099_CR198","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s10753-020-01298-7","volume":"43","author":"Q Zou","year":"2020","unstructured":"Zou Q, et al. Influences of regulation of miR-126 on inflammation,Th17\/Treg subpopulation differentiation, and lymphocyte apoptosis through caspase signaling pathway in sepsis. Inflammation. 2020;43(6):2287\u2013300.","journal-title":"Inflammation"},{"issue":"1","key":"5099_CR199","doi-asserted-by":"crossref","first-page":"17691","DOI":"10.1038\/s41598-020-74965-2","volume":"10","author":"D Liu","year":"2020","unstructured":"Liu D, et al. The protective role of miR-223 in sepsis-induced mortality. Sci Rep. 2020;10(1):17691.","journal-title":"Sci Rep"},{"key":"5099_CR200","first-page":"9948229","volume":"2022","author":"C Liu","year":"2022","unstructured":"Liu C, Zou Q. miR-21 regulates immune balance mediated by Th17\/treg in peripheral blood of septic rats during the early phase through apoptosis pathway. Biochem Res Int. 2022;2022:9948229.","journal-title":"Biochem Res Int"},{"issue":"7","key":"5099_CR201","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/iub.2033","volume":"71","author":"JX Chen","year":"2019","unstructured":"Chen JX, Xu X, Zhang S. Silence of long noncoding RNA NEAT1 exerts suppressive effects on immunity during sepsis by promoting microRNA-125-dependent MCEMP1 downregulation. IUBMB Life. 2019;71(7):956\u201368.","journal-title":"IUBMB Life"},{"issue":"4","key":"5099_CR202","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbrc.2019.04.051","volume":"513","author":"JN Deng","year":"2019","unstructured":"Deng JN, et al. Exosomes derived from plasma of septic patients inhibit apoptosis of T lymphocytes by down-regulating bad via hsa-miR-7-5p. Biochem Biophys Res Commun. 2019;513(4):958\u201366.","journal-title":"Biochem Biophys Res Commun"},{"key":"5099_CR203","doi-asserted-by":"crossref","first-page":"110488","DOI":"10.1016\/j.intimp.2023.110488","volume":"121","author":"Z Feng","year":"2023","unstructured":"Feng Z, et al. Intermedin (adrenomedullin 2) plays a protective role in sepsis by regulating T- and B-cell proliferation and activity. Int Immunopharmacol. 2023;121:110488.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5099_CR204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.intimp.2015.04.034","volume":"27","author":"JS Kim","year":"2015","unstructured":"Kim JS, Kim SJ, Lee SM. Genipin attenuates sepsis-induced immunosuppression through inhibition of T lymphocyte apoptosis. Int Immunopharmacol. 2015;27(1):15\u201323.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"5099_CR205","doi-asserted-by":"crossref","first-page":"e0131680","DOI":"10.1371\/journal.pone.0131680","volume":"10","author":"D Liang","year":"2015","unstructured":"Liang D, et al. Decoy receptor 3 improves survival in experimental Sepsis by suppressing the inflammatory response and lymphocyte apoptosis. PLoS ONE. 2015;10(6):e0131680.","journal-title":"PLoS ONE"},{"issue":"4","key":"5099_CR206","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thoraxjnl-2021-217526","volume":"78","author":"Y Lai","year":"2023","unstructured":"Lai Y, et al. Protein arginine N-methyltransferase 4 (PRMT4) contributes to Lymphopenia in experimental sepsis. Thorax. 2023;78(4):383\u201393.","journal-title":"Thorax"},{"key":"5099_CR207","doi-asserted-by":"crossref","first-page":"34702","DOI":"10.1038\/srep34702","volume":"6","author":"M Doerflinger","year":"2016","unstructured":"Doerflinger M, et al. Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice. Sci Rep. 2016;6:34702.","journal-title":"Sci Rep"},{"issue":"1","key":"5099_CR208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamainternmed.2020.5503","volume":"181","author":"L-l Cheng","year":"2021","unstructured":"Cheng L-l, et al. Effect of recombinant human granulocyte colony\u2013stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):71\u20138.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"5099_CR209","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.202111-2493OC","volume":"205","author":"I Popescu","year":"2022","unstructured":"Popescu I, et al. CD4\u2009+\u2009T-cell dysfunction in severe COVID-19 disease is tumor necrosis factor-\u03b1\/tumor necrosis factor receptor 1\u2013dependent. Am J Respir Crit Care Med. 2022;205(12):1403\u201318.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5099_CR210","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12879-024-09286-0","volume":"24","author":"T Inui","year":"2024","unstructured":"Inui T, et al. Effect of degalactosylated bovine glycoprotein formulations MAF and M \u0441apsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial. BMC Infect Dis. 2024;24(1):519.","journal-title":"BMC Infect Dis"},{"key":"5099_CR211","doi-asserted-by":"crossref","first-page":"1009557","DOI":"10.3389\/fmed.2022.1009557","volume":"9","author":"W-Y Wang","year":"2022","unstructured":"Wang W-Y, et al. A case series report on successful management of patients with COVID-19-associated lymphopenia and potential application of PG2. Front Med. 2022;9:1009557.","journal-title":"Front Med"},{"issue":"4","key":"5099_CR212","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/eji.200939739","volume":"40","author":"WF Carson","year":"2010","unstructured":"Carson WF, et al. Impaired CD4\u2009+\u2009T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis. Eur J Immunol. 2010;40(4):998\u20131010.","journal-title":"Eur J Immunol"},{"issue":"6","key":"5099_CR213","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn M, Kroemer G. Hallmarks of T cell aging. Nat Immunol. 2021;22(6):687\u201398.","journal-title":"Nat Immunol"},{"issue":"1","key":"5099_CR214","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12979-023-00357-5","volume":"20","author":"RG Snodgrass","year":"2023","unstructured":"Snodgrass RG, et al. Cumulative physiological stress is associated with age-related changes to peripheral T lymphocyte subsets in healthy humans. Immun Ageing. 2023;20(1):29.","journal-title":"Immun Ageing"},{"issue":"10","key":"5099_CR215","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/jcm10102075","volume":"10","author":"W Wasyluk","year":"2021","unstructured":"Wasyluk W, Wasyluk M, Zwolak A. Sepsis as a pan-endocrine illness\u2014endocrine disorders in septic patients. J Clin Med. 2021;10(10):2075.","journal-title":"J Clin Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-05099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-05099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T05:04:00Z","timestamp":1726808640000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-05099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":215,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5099"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-05099-4","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}